Skip to main content
. 2018 Jun 26;9:674. doi: 10.3389/fphar.2018.00674

Table 4.

Percentages of cells in each phase of cell cycle (%).

DPCs
ORSCs
G1 phase S phase G2/M phase G1 phase S phase G2/M phase
Control 65.00 ± 1.32 16.44 ± 1.12 17.85 ± 1.72 64.83 ± 2.60 13.75 ± 1.14 20.58 ± 2.05
EGCG 50.20 ± 1.83### 23.35 ± 2.30## 24.98 ± 2.40# 56.53 ± 3.39# 23.95 ± 2.85## 18.71 ± 1.76
Cyclopamine 69.72 ± 2.87 12.21 ± 1.52 17.65 ± 1.76 66.34 ± 2.20 10.36 ± 1.09 22.14 ± 2.46
EGCG+ Cyclopamine 64.51 ± 3.14∗∗ 16.86 ± 1.70 18.01 ± 1.71 63.13 ± 4.05 15.28 ± 1.90 20.47 ± 2.44
GANT61 72.98 ± 2.36 12.31 ± 1.69 13.47 ± 1.94 66.10 ± 2.37 10.38 ± 1.60 22.35 ± 2.61
EGCG+ GANT61 65.66 ± 2.37∗∗∗ 17.38 ± 2.19 16.76 ± 1.78∗∗ 63.87 ± 1.22 14.71 ± 1.77∗∗ 20.75 ± 2.18
LY2940002 70.24 ± 1.52 11.84 ± 1.57 17.19 ± 1.85 68.20 ± 2.87 10.21 ± 1.82 20.80 ± 2.32
EGCG+ LY2940002 56.06 ± 2.98 18.56 ± 1.91 24.50 ± 1.09 65.16 ± 3.45 15.12 ± 1.73 18.84 ± 3.77

The results are presented as mean ± SD. #p < 0.05, ##p < 0.01, ###p < 0.001 compared with the Control group. p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 compared with the EGCG group.